Viewing Study NCT03366350


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2026-01-24 @ 9:49 PM
Study NCT ID: NCT03366350
Status: UNKNOWN
Last Update Posted: 2019-05-10
First Post: 2017-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies
Sponsor: Wuhan Sian Medical Technology Co., Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None B Cell Lymphoma View
Keywords: